0001645113-23-000012.txt : 20230110
0001645113-23-000012.hdr.sgml : 20230110
20230110161446
ACCESSION NUMBER: 0001645113-23-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230106
FILED AS OF DATE: 20230110
DATE AS OF CHANGE: 20230110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benaim Ely
CENTRAL INDEX KEY: 0001632237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 23521297
MAIL ADDRESS:
STREET 1: C/O REXAHN PHARMACEUTICALS, INC.
STREET 2: 15245 SHADY GROVE ROAD, SUITE 455
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_167338526960077.xml
FORM 4
X0306
4
2023-01-06
0
0001645113
NovoCure Ltd
NVCR
0001632237
Benaim Ely
C/O NOVOCURE INC.,
1550 LIBERTY RIDGE DRIVE, SUITE 115
WAYNE
PA
19087
0
1
0
0
Chief Medical Officer
Ordinary Shares
2023-01-06
5
A
0
E
98
62.305
A
28770
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022.
/s/ Steven Robbins Attorney in Fact for Ely Benaim
2023-01-10